Furthermore, the study from Potchiurko et al. showed that NT-proBNP levels ≥ 3537 pg/mL at 8–9 days of life have a great diagnostic capacity for BPD progression independently from PDA persistence. This evidence concerns the gene NPPB and Patent ductus arteriosus.